These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17058213)

  • 1. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?
    de Vos P; de Haan BJ; Kamps JA; Faas MM; Kitano T
    J Biomed Mater Res A; 2007 Mar; 80(4):813-9. PubMed ID: 17058213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions.
    van Hoogmoed CG; Busscher HJ; de Vos P
    J Biomed Mater Res A; 2003 Oct; 67(1):172-8. PubMed ID: 14517874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating.
    King A; Strand B; Rokstad AM; Kulseng B; Andersson A; Skjåk-Braek G; Sandler S
    J Biomed Mater Res A; 2003 Mar; 64(3):533-9. PubMed ID: 12579568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition.
    Ponce S; Orive G; Hernández R; Gascón AR; Pedraz JL; de Haan BJ; Faas MM; Mathieu HJ; de Vos P
    Biomaterials; 2006 Oct; 27(28):4831-9. PubMed ID: 16766026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules.
    Clayton HA; London NJ; Colloby PS; Bell PR; James RF
    J Microencapsul; 1991; 8(2):221-33. PubMed ID: 1765902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid.
    de Haan BJ; Rossi A; Faas MM; Smelt MJ; Sonvico F; Colombo P; de Vos P
    J Biomed Mater Res A; 2011 Sep; 98(3):394-403. PubMed ID: 21630432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules.
    Bünger CM; Gerlach C; Freier T; Schmitz KP; Pilz M; Werner C; Jonas L; Schareck W; Hopt UT; de Vos P
    J Biomed Mater Res A; 2003 Dec; 67(4):1219-27. PubMed ID: 14624508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells.
    de Vos P; Hoogmoed CG; Busscher HJ
    J Biomed Mater Res; 2002 May; 60(2):252-9. PubMed ID: 11857431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility investigation of polyethylene glycol and alginate-poly-L-lysine for islet encapsulation.
    Liu XY; Nothias JM; Scavone A; Garfinkel M; Millis JM
    ASAIO J; 2010; 56(3):241-5. PubMed ID: 20400892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy.
    Orive G; Tam SK; Pedraz JL; Hallé JP
    Biomaterials; 2006 Jul; 27(20):3691-700. PubMed ID: 16574222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of alginate-poly-L-lysine-alginate microcapsules by confocal laser scanning microscopy.
    Strand BL; Mørch YA; Espevik T; Skjåk-Braek G
    Biotechnol Bioeng; 2003 May; 82(4):386-94. PubMed ID: 12632394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions.
    Ma X; Vacek I; Sun A
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(1):43-69. PubMed ID: 8055097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules.
    de Vos P; Spasojevic M; de Haan BJ; Faas MM
    Biomaterials; 2012 Aug; 33(22):5552-9. PubMed ID: 22560199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the tissue response against alginate-pll capsules by temporary release of co-encapsulated steroids.
    Bünger CM; Tiefenbach B; Jahnke A; Gerlach C; Freier T; Schmitz KP; Hopt UT; Schareck W; Klar E; de Vos P
    Biomaterials; 2005 May; 26(15):2353-60. PubMed ID: 15585238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
    Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
    Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcapsules made by enzymatically tailored alginate.
    Strand BL; Mørch YA; Syvertsen KR; Espevik T; Skjåk-Braek G
    J Biomed Mater Res A; 2003 Mar; 64(3):540-50. PubMed ID: 12579569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period.
    de Vos P; van Hoogmoed CG; de Haan BJ; Busscher HJ
    J Biomed Mater Res; 2002 Dec; 62(3):430-7. PubMed ID: 12209929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules.
    De Vos P; De Haan B; Van Schilfgaarde R
    Biomaterials; 1997 Feb; 18(3):273-8. PubMed ID: 9031730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines.
    Strand BL; Ryan TL; In't Veld P; Kulseng B; Rokstad AM; Skjak-Brek G; Espevik T
    Cell Transplant; 2001; 10(3):263-75. PubMed ID: 11437072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats.
    Dufrane D; Steenberghe Mv; Goebbels RM; Saliez A; Guiot Y; Gianello P
    Biomaterials; 2006 Jun; 27(17):3201-8. PubMed ID: 16497373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.